Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their efforts on the development of novel gene editing therapies. In fact, the gene therapy pipeline has evolved significantly over the past few years, with three products being approved in 2019 alone; namely Beperminogene perplasmid (AnGes), ZOLGENSMA® (AveXis) and ZYNTEGLO™ (bluebird bio). Further, there are multiple pipeline candidates in mid to late-stage (phase II and above) trials that are anticipated to enter the market over the next 5-10 years.
To order this 670+ page report, which features 190+ figures and 340+ tables, please visit this link
The USD 11.6 billion (by 2030) financial opportunity within the gene therapy market has been analyzed across the following segments:
The Gene Therapy Market (3rd Edition), 2019-2030 report features the following companies, which we identified to be key players in this domain:
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Gene Delivery Vectors
5. Regulatory Landscape and Reimbursement Scenario
6. Competitive Landscape
7. Marketed Gene Therapies
8. Key Commercialization Strategies
9. Late Stage (Phase II/III and Above) Gene Therapies
10. Emerging Technologies
11. Promising Therapeutics Areas
12. Patent Analysis
13. Mergers and Acquisitions
14. Funding and Investment Analysis
15. Cost Price Analysis
16. Big Pharma Players: Analysis of Gene Therapy Related Initiatives
17. Market Forecast and Opportunity Analysis
18. Vector Manufacturing
19. Case Study: Gene Therapy Supply Chain
20. Conclusion
21. Interview Transcripts
22. Appendix 1: Tabulated Data
23. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
- CertsLeads enables you to prepare your certification exams, Get most actual and updated exam questions PDF for passing the certifications exam in first attempt
- CBA Exam, CBA questions, CBA practice test, CBA practice exam, CBA dumps, CBA Exam Dumps, CBA exam questions,
- underwater was 51ft. ULCV is a specification given to a craft with a capacity greater than 20,000 twenty-foot equivalent units. T
- The ride-hailing business is bigger than the food delivery business because when people are relying on Uber—like you did before you got your car, you were taking it every single day, potentially